Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Similars in SciELO
Share
Ginecología y obstetricia de México
Print version ISSN 0300-9041
Abstract
DARDANO-BERRIEL, Andrés et al. Mammary metastasis of mantle cell lymphoma. Ginecol. obstet. Méx. [online]. 2018, vol.86, n.11, pp.740-743. Epub Oct 02, 2020. ISSN 0300-9041. https://doi.org/10.24245/gom.v86i11.1979.
BACKGROUND:
Primary mammary lymphomas represent less than 1% of all Non Hodgking Lymphomas (NHL). Mantle cell lymphoma (MCL) represents 4% of lymphomas in the United States, and 7-9% in Europe and is diagnosed in patients with a median age of 60 years. Unilateral painless mammary mass in postmenopausal women use to be the clinical presentation. Secondary breast lymphoma is defined as the presence of systemic lymphoma with breast involvement, as the patient below.
CLINICAL CASE:
57-year-old female patient with post-traumatic mammary tumor, with history of thrombocytopenia, first-time diagnosed of hematoma, with breast enlargement and later diagnosed as lymphoma of mantle cells with pathology test and classified as secondary to previous inguinal nodal lymphoma.
CONCLUSIONS:
It is important to keep in mind this diagnosis in view of the persistence or rapid growth of a mammary hematoma or other lesion with benign radiological appearance. The biopsy is the gold standard for diagnosis, since it allows the histological and immunohistochemical study, for molecular confirmation. The treatment is mainly based on chemo / radiotherapy, which improves survival and decreases recurrence.
Keywords : Mantle cell lymphoma; Unilateral painless mammary mass; Postmenopausal women; Secondary breast lymphoma, Traumatic mammary tumor; Thrombocytopenia.